Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Rottenberg

Showing results (81-90 of 122) with videos related to

Pageof 13
Sort By:
Virchows Archiv : an International Journal of Pathology|May 27, 2022
Towards a national strategy for digital pathology in SwitzerlandAndrew Janowczyk, Daniel Baumhoer, Stefan Dirnhofer, et al.
Oncotarget|August 28, 2016
Secretome proteomics reveals candidate non-invasive biomarkers of BRCA1 deficiency in breast cancerMarc Warmoes, Siu W Lam, Petra van der Groep, et al.
Genome Biology|April 19, 2015
CopywriteR: DNA copy number detection from off-target sequence dataThomas Kuilman, Arno Velds, Kristel Kemper, et al.
Nature|July 27, 2018
53BP1 cooperation with the REV7-shieldin complex underpins DNA structure-specific NHEJHind Ghezraoui, Catarina Oliveira, Jordan R Becker, et al.
Gene Therapy|March 12, 2026
Spatial transcriptomics and single-nucleus RNA sequencing reveal rAAV2- and rAAV9-specific transduction signatures in the mouse liverBettina Amberg, Fabian Köchl, Nadine Kumpesa, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 13, 2007
Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancerSven Rottenberg, Anders O H Nygren, Marina Pajic, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 24, 2015
Selective resistance to the PARP inhibitor olaparib in a mouse model for BRCA1-deficient metaplastic breast cancerLinda Henneman, Martine H van Miltenburg, Ewa M Michalak, et al.
Nucleic Acids Research|April 10, 2025
The PIN1-p38-CtIP signalling axis protects stalled replication forks from deleterious degradationFrancesca Vivalda, Marco Gatti, Letizia Manfredi, et al.
Cancer Discovery|April 25, 2019
PARP Inhibitor Efficacy Depends on CD8<sup>+</sup> T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast CancerConstantia Pantelidou, Olmo Sonzogni, Mateus De Oliveria Taveira, et al.
Cancer Discovery|October 30, 2012
Loss of 53BP1 causes PARP inhibitor resistance in Brca1-mutated mouse mammary tumorsJanneke E Jaspers, Ariena Kersbergen, Ute Boon, et al.
Pageof 13

Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
Virchows Archiv : an International Journal of Pathology|May 27, 2022
Towards a national strategy for digital pathology in SwitzerlandAndrew Janowczyk, Daniel Baumhoer, Stefan Dirnhofer, et al.
Oncotarget|August 28, 2016
Secretome proteomics reveals candidate non-invasive biomarkers of BRCA1 deficiency in breast cancerMarc Warmoes, Siu W Lam, Petra van der Groep, et al.
Genome Biology|April 19, 2015
CopywriteR: DNA copy number detection from off-target sequence dataThomas Kuilman, Arno Velds, Kristel Kemper, et al.
Nature|July 27, 2018
53BP1 cooperation with the REV7-shieldin complex underpins DNA structure-specific NHEJHind Ghezraoui, Catarina Oliveira, Jordan R Becker, et al.
Gene Therapy|March 12, 2026
Spatial transcriptomics and single-nucleus RNA sequencing reveal rAAV2- and rAAV9-specific transduction signatures in the mouse liverBettina Amberg, Fabian Köchl, Nadine Kumpesa, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 13, 2007
Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancerSven Rottenberg, Anders O H Nygren, Marina Pajic, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 24, 2015
Selective resistance to the PARP inhibitor olaparib in a mouse model for BRCA1-deficient metaplastic breast cancerLinda Henneman, Martine H van Miltenburg, Ewa M Michalak, et al.
Nucleic Acids Research|April 10, 2025
The PIN1-p38-CtIP signalling axis protects stalled replication forks from deleterious degradationFrancesca Vivalda, Marco Gatti, Letizia Manfredi, et al.
Cancer Discovery|April 25, 2019
PARP Inhibitor Efficacy Depends on CD8<sup>+</sup> T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast CancerConstantia Pantelidou, Olmo Sonzogni, Mateus De Oliveria Taveira, et al.
Cancer Discovery|October 30, 2012
Loss of 53BP1 causes PARP inhibitor resistance in Brca1-mutated mouse mammary tumorsJanneke E Jaspers, Ariena Kersbergen, Ute Boon, et al.
Pageof 13